Skip to main content
Log in

GnRH receptors in human breast cancer and its contiguous not-involved breast tissue

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The present study was undertaken to evaluate the presence of GnRH receptors (GnRH-R) in breast cancer and not-involved breast tissue, and the relationships between GnRH-R and receptors for estrogen (ER) and progesterone (PgR) in the same tissues. Utilizing a tritiated natural GnRH in order to assay the native receptor binding we analyzed the level of binding sites for GnRH in membranes derived from 90 breast tumors and in 40 cases from neighboring, not-involved breast tissue. GnRH-R was found both in cancer and normal tissues. The prevalence for GnRH-R was higher in tumor than in not-tumor tissue (45% vs 39%, respectively), but the overall levels were not significantly different (15.9±24 fmol/mg protein vs 18.2±39 fmol/mg protein, respectively). The only statistically different content of GnRH-R we found concerned PgR negative vs PgR positive tumor tissues (mean content: 23 vs 11 fmol/mg protein, respectively in PgRand PgR+ tumors, p=0.03 by t test); furthermore the proportion of GnRH-R positive cases in the tumor resulted significantly higher in premenopausal patients vs postmenopausal (56% vs 32%, by Chi square test, p<0.05). The GnRH receptors status of primary tumor and contiguous notinvolved breast tissue resulted associated (overall agreement: 63%, p<0.05) but no specific steroid patterns for GnRH-R positivity was observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kaufmann M. Zoladex in treatment of premenopausal metastatic breast cancer patients. Horm. Res. 1989, 32(Suppl. 1): 202–205.

    Article  PubMed  Google Scholar 

  2. Klijn J.G.M., De Jong F.H., Lamberts S.W.J., Blankenstein M.A. LHRH-agonist treatment in clinical and experimental human breast cancer. J. Steroid Biochem. 1985, 23: 867–873.

    Article  CAS  PubMed  Google Scholar 

  3. Nicholson R.I., Walker K.J., MeClelland R.A., Dixon A., Robertson R.I., Blamcy R.W. Zoladex plus tamoxifen versus Zoladex alone in pre and perimenopausal metastatic breast cancer. J. Steroid Biochem. Molec. Biol. 1990, 37: 989–995.

    Article  CAS  PubMed  Google Scholar 

  4. Fekete M., Zalatmai A., Comaru-Schally A.M., Schally A.V. Membrane receptors for peptides in experimental and human pancreatic cancers. Pancreas 1989, 4: 521–528.

    Article  CAS  PubMed  Google Scholar 

  5. Srkalovic G., Wittliff J.L., Schally A.V. Detection and partial characterization of receptors for (D-Trp6)-luteinizing-hormone releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res. 1990, 50: 1841–1846.

    CAS  PubMed  Google Scholar 

  6. Emons G., Pahwa G.S., Brack C., Sturm R., Oberheuser F., Knuppen R. Gonadotrophin-releasing-hormone binding sites in human epitelial ovarian carcinoma. Eur. J. Cancer Clin. Oncol. 1989, 25: 215–221.

    Article  CAS  PubMed  Google Scholar 

  7. Eidne K.A., Flanagan C.A., Harris N.S., Millar R.P. Gonadotrophin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J. Clin. Endocrinol. Metab. 1987, 64: 425–432.

    Article  CAS  PubMed  Google Scholar 

  8. Miller W.R., Scott W.N., Morris R., Fraser N.M., Sharpe R.M. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 1985, 313: 231–233.

    Article  CAS  PubMed  Google Scholar 

  9. Fekete M., Wittliff J.L., Schally A.V. Characteristics and distribution of receptors for (D-Trp6)-luteinizing-hormone releasing hormone, somatostatin, epidermal grow factor and sex steroids in 500 biopsy samples of human breast cancer. J. Clin. Lab. Analysis 1989, 3: 137–147.

    Article  CAS  Google Scholar 

  10. Baumann K.H., Kiesel L., Kaumann M., Bastert G., Runnebaurn B. Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters. Breast Cancer Res. Treat. 1993, 25: 37–46.

    Article  CAS  PubMed  Google Scholar 

  11. Mullen P., Bramley T., Menzies G., Miller B. Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissues and in MCF-7 and MDA-MB-231 cancer cells. Eur. J. Cancer 1993, 29 A: 248–252.

    Article  CAS  PubMed  Google Scholar 

  12. Chatzaki E., Bax C.M.R., Eidne K.A., Anderson L., Grudzinskas J.G., Gallagher C.J. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth-factor. Cancer Res. 1996, 56: 2059–2065.

    CAS  PubMed  Google Scholar 

  13. Bazam T., Koch Y., Hazum E., Fridkin M. Gonadotropin-releasing hormone in milk. Science 1977, 198: 300–302.

    Article  Google Scholar 

  14. Harris N., Dutlow C., Eidne K.A., Dongk W., Roberts J., Millar R. Gonadotropin-releasing hormone gene expression in MDA-MB-231 and ZR-75-1 breast carcinoma cell lines. Cancer Res. 1991, 51: 2577–2581.

    CAS  PubMed  Google Scholar 

  15. Duval D.L., Nelson S.E., Clay C.M. The tripartite basal enhancer of the gonadotropin-releasing hormone (GnRH) receptor gene promoter regulates cell-specific expression through a novel GnRH receptor activating sequence. Mol. Endocrinol. 1997, 11: 1814–1821.

    Article  CAS  PubMed  Google Scholar 

  16. Reshkin S.J., Albarani V., Pezzetta A., Marinaccio M., Paradiso A. Gonadotrophin releasing hormone (GnRH) receptor and steroid receptors in human uterine leiomyoma, myometrium and endometrium. Int. J. Oncol. 1997, 11: 603–607.

    CAS  PubMed  Google Scholar 

  17. Fisher E.R., Gregorio R.M., Fisher B. The pathology of invasive breast cancer: a syllabus derived from findings of the NSABP. Cancer 1975, 36: 1–85.

    Article  CAS  PubMed  Google Scholar 

  18. Piffanelli A., Pelizzola D., Giovannini G., Catozzi L., Faggioli L., Giganti M. Characterization of laboratory working standards for quality control of immunometric and radiometric estrogen receptor assays. Tumori 1989, 75: 550–556.

    CAS  PubMed  Google Scholar 

  19. Waddel/Hill. In: J. Lab. Clin. Med. 1956, 48: 311–314.

    Google Scholar 

  20. Scatchard G. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci 1949, 51: 660–672.

    Article  CAS  Google Scholar 

  21. Paradiso A., Mangia A., Barletta A., Fusilli S., Marzullo F., Schittulli F., De Lena M. Heterogeneity of intratumor proliferative activity in primary breast cancer: biological and clinical aspects. Eur. J. Cancer 1995, 31A: 911–916.

    Article  CAS  PubMed  Google Scholar 

  22. Kakar S.S., Grizzle W.E., Neill J.D. The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol. Cell. Endocrinol. 1994, 106: 146–149.

    Article  Google Scholar 

  23. Kottler M.L., Starzec A., Carre M.C., Lagarde J.P., Martin A., Counis R. The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer. Int. J. Cancer 1997, 71: 595–599.

    Article  CAS  PubMed  Google Scholar 

  24. Eidne K.A., Flanagan C.A., Millar R.P. Gonadotropin-releasing hormone binding sites in human breast carcinoma. Science 1985, 229: 989–991.

    Article  CAS  PubMed  Google Scholar 

  25. Reshkin S.J., Pezzetta A., Albarani V., Schittulli F. Paradiso A. Characterization of a 3H-GnRH method for the measurement of GnRH binding sites in human breast cancer and breast cancer cell lines. Int. J. Oncol. 1995, 7: 371–375.

    CAS  PubMed  Google Scholar 

  26. Radovick S., Ticknor C.M., Nakayama Y., Notides A.L.C., Raham A., Weintraub B.D., Cutler G.B.Jr., Wondisford E.E. Evidence for direct estrogen regulation of the human gonadotropin releasing hormone gene. J. Clin. Invest. 1991, 88: 1649–1655.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Motta M. Direct antiproliferative effect of LHRH agonists on human prostatic tumor cells: possible mechanism of action. Gynecol. Endocrinol. 1999, 13 (Suppl 1): 11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angelo Paradiso.

Additional information

Finanziato parzialmente da AIRC e CNR

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paradiso, A., Pezzetta, A., Cellamare, G. et al. GnRH receptors in human breast cancer and its contiguous not-involved breast tissue. J Endocrinol Invest 23, 90–96 (2000). https://doi.org/10.1007/BF03343685

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343685

Keywords

Navigation